0001493152-21-008207.txt : 20210407 0001493152-21-008207.hdr.sgml : 20210407 20210407162141 ACCESSION NUMBER: 0001493152-21-008207 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20210407 DATE AS OF CHANGE: 20210407 EFFECTIVENESS DATE: 20210407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Edison Oncology Holding Corp CENTRAL INDEX KEY: 0001753347 IRS NUMBER: 831614120 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-394960 FILM NUMBER: 21812366 BUSINESS ADDRESS: STREET 1: 3475 EDISON WAY STREET 2: SUITE R CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650)690-1927 MAIL ADDRESS: STREET 1: 3475 EDISON WAY STREET 2: SUITE R CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0708 D LIVE 0001753347 Edison Oncology Holding Corp 3475 EDISON WAY, SUITE R MENLO PARK CA CALIFORNIA 94025 6506901927 NEVADA None None Corporation true 2018 Jeffrey A Bacha 5973 N. 83rd St. Scottsdale AZ ARIZONA 85250 Executive Officer Director Pharmaceuticals Decline to Disclose 06c false 2020-12-30 false true true true true Notes convertible into common stock false 0 NewBridge Securities Corporation 104065 None None 1200 NORTH FEDERAL HIGHWAY SUITE 400 BOCA RATON FL FLORIDA 33432 All States false 1500000 250000 1250000 Offering terminates 31-Mar/2021 false 7 25000 0 Newbridge Securities (NSC) paid 8% placement fee + 2% non-accountable fee. NSC contract terminated by mutual agreement 2-Feb/2021 0 false Edison Oncology Holding Corp /s/ Jeffrey A. Bacha Jeffrey A. Bacha Chief Executive Officer 2021-04-07